Table Olives: A Carrier for Delivering Probiotic Bacteria to Humans

Olives and Olive Oil in Health and Disease Prevention

Volumn , Issue , 2010, Pages 735-743

  Lavermicocca, Paola ^a   Rossi, Mauro ^a   Russo, Francesco ^b   Srirajaskanthan, Rajaventhan ^c  

^a INSTITUTE OF SCIENCES OF FOOD PRODUCTION   (Italy)

^b CNR   (Italy)

^c Natl Inst of Digestive Diseases   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882927918     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374420-3.00077-2     Document Type: Chapter

References (29)

1. Bekkali N., Bongers M.E.J., Van den Berg M.M., Liem O., Benninga M.A. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study. Nutr. J. 2007, 6:17.
2. Di Marzio L., Russo F.P., D'Alò S., Biordi L., Ulisse S., Amicosante G., De Simone C., Cifone M.G. Apoptotic effects of selected strains of lactic acid bacteria on a human T leukaemia cell line are associated with bacterial arginine deiminase and/or sphigomyelinase activities. Nutr. Cancer 2001, 40:185-196.
3. FAO/WHO. Report on Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. 2001. ftp://ftp.fao.org/es/esn/food/probio_report_en.pdf.
4. Furrie E. Probiotics and allergy. Pro. Nutr. Soc. 2005, 64:465-469.
5. Haller D., Blum S., Bode C., Hammes W.P., Schiffrin E.J. Activation of human peripheral blood mononuclear cells by non-pathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect. Immun. 2000, 68:752-759.
6. Kato I., Endo-Tanaka K., Yokokura T. Suppressive effects of the oral administration of Lactobacillus casei one type II collagen-induced arthritis in DBA/1 mice. Life Sci. 1998, 63:635-644.
7. Jass J.R., Whitehall V.L., Young J., Leggett B.A. Emerging concepts in colorectal neoplasia. Gastroenterology 2002, 123:862-876.
8. Jonkers D., Stockbrügger R. Review article: probiotics in gastrointestinal and liver diseases. Aliment. Pharmacol. Ther. 2007, 26(Suppl 2):133-148.
9. Lavermicocca P., Valerio F., Lonigro S.L., Di Leo A., Visconti A. Antagonistic activity of potential probiotic lactobacilli against the ureolytic pathogen Yersinia enterocolitica. Curr. Microbiol. 2008, 56:175-181.
10. Lavermicocca P. Highlights on new food research. Dig. Liver Dis. 2006, 38:S295-S299.
11. Lavermicocca, P., Lonigro, S.L., Visconti, A., De Angelis, M., Valerio, F., Morelli, L., 2005a. Table olives containing probiotic micro-organisms. Patent application WO 2005/053430A1.
12. Lavermicocca P., Valerio F., Lonigro S.L., De Angelis M., Morelli L., Callegari M.L., Rizzello C.G., Visconti A. Adhesion and survival of Lactobacilli and Bifidobacteria on table olives with the aim of formulating a new probiotic food. Appl. Environ. Microbiol. 2005, 71:4233-4240.
13. Linsalata M., Russo F., Berloco P., Valentini A.M., Caruso M.L., De Simone C., Barone M., Polimeno L., Di Leo A. Effects of probiotic bacteria (VSL#3) on the polyamine biosynthesis and cell proliferation of normal colonic mucosa of rats. In vivo 2005, 19:989-996.
14. Maassen C.B., van Holten-Neelen C., Balk F., den Bak-Glashouwer M.J., Leer R.J., Laman J.D., Boersma W.J., Claassen E. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 2000, 18:2615-2623.
15. Maukonen J., Alakomi H.L., Nohynek L., Hallamaa K., Leppämäki S., Mättö J., Saarela M. Suitability of the fluorescent techniques for the enumeration of probiotic bacteria in commercial non-dairy drinks and in pharmaceutical products. Food Res. Int. 2006, 39:22-32.
16. Mohamadzadeh M., Olson S., Kalina W.V., Ruthel G., Demmin G.L., Warfield K.L., Bavari S., Klaenhammer T.R. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc. Natl. Acad. Sci. USA 2005, 102:2880-2885.
17. Oberreuther-Moschner D.L., Jahreis G., Rechkemmer G., Pool-Zobel B.L. Dietary intervention with the probiotics Lactobacillusacidophilus 145 and Bifidobacterium longum 913 modulates the potential of human faecal water to induce damage in HT29clone 19A cells. Br. J. Nutr. 2004, 91:925-932.
18. Peng H.F., Jackson V. In vitro studies on the maintenance oftranscription-induced stress by histones and polyamines. J. Biol. Chem. 2000, 275:657-668.
19. Perdigon G., de Macias M.E., Alvarez S., Oliver G., de Ruiz H. Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus. Immunology 1988, 63:17-23.
20. Perez Chaia A., Oliver G. Intestinal microflora and metabolic activity. Gut Flora, Nutrition, Immunity and Health 2003, 77-98. Blackwell Publishing, Oxford, UK. R. Fuller, G. Perdigón (Eds.).
21. Picard C., Fioramonti J., Francois A., Robinson T., Neant F., Matuchansky C. Review article: bifidobacteria as probiotic agents - physiological effects and clinical benefits. Aliment. Pharmacol. Ther. 2005, 22:495-512.
22. Pool-Zobel B.L., Neudecker C., Domizla I., Ji S., Schillinger U., Rumney C., Moretti M., Vilarini I., Scassellati-Sforzolini R., Rowland I. Lactobacillus- and Bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr. Cancer 1996, 26:365-380.
23. Rachmilewitz D., Katakura K., Karmeli F., Hayashi T., Reinus C., Rudensky B., Akira S., Takeda K., Lee J., Takabayashi K., Raz E. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126:520-528.
24. Randazzo C.L., Restuccia C., Romano A.D., Caggia C. Lactobacillus casei, dominant species in naturally fermented Sicilian green olives. Int. J. Food Microbiol. 2004, 90:9-14.
25. Rangavajhyala N., Shahani K.M., Sridevi G., Srikumaran S. Nonlipopolysaccharide component(s) of Lactobacillus acidophilus stimulate(s) the production of interleukin-1 alpha and tumor necrosis factor-alpha by murine macrophages. Nutr. Cancer 1997, 28:130-134.
26. Sartor R.B. Probiotic therapy of intestinal inflammation and infections. Curr. Opin. Gastroenterol. 2005, 21:44-50.
27. Schiffrin E.J., Brassart D., Servin A.L., Rochat F., Donnet-Hughes A. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am. J. Clin. Nutr. 1997, 66:515S-520S.
28. Valerio F., De Bellis P., Lonigro S.L., Morelli L., Visconti A., Lavermicocca P. In vitro and in vivo survival and transit tolerance of potentially probiotic strains carried by artichokes in the gastrointestinal tract. Appl. Environ. Microbiol. 2006, 72:3042-3045.
29. Van den Berg D.J.C., Smits A., Pot B., Ledeboer A.M., Kesters K., Verbakel J.M.A., Verrips C.T. Isolation, screening and identification of lacto acid bacteria from traditional food fermentation processes and culture collections. Food Biotechnol. 1993, 7:189-205.